Embryo development, cancer progression and tissue regeneration have in common a strong dependency on stem and progenitor cells. What are the shared characteristics and differences between those embryonic, cancer and adult stem cells is still an open question. Are cancer stem cells derived from adult stem cells or differentiated cancer cells that acquired stem cell properties? What determines the potency of embryonic and adult stem cells? These questions and many others await a better understanding of stem cell properties in different contexts.
To address this challenge, the second conference “Stem Cells and Cancer” to be held in Lyon on Nov. 15-16, 2016 is aimed at bringing together world experts in the fields of embryonic, adult and cancer stem cells. The synergy created by the reunion of leaders at the crossroad of those research themes will highlight novel approaches to address the important challenges associated with stem cells biology and therapeutics.